Anders Liljeblad — Board member
Get alerts when Anders Liljeblad trades
Alerts for a single person aren't available yet, so you'll follow the companies where they're an insider: Prostatype Genomics AB.
12-month summary
Net buyer over the last 12 months
1 open-market buy, 0 sales, 0 share awards · SEK 575,000.00 bought, SEK 0.00 sold
Roles
31.08.2026 – 15.09.2026
Transactions (including via associated entities)
| Date | Issuer | Transaction type | Volume | Price | Value | Source |
|---|---|---|---|---|---|---|
| 15.09.2026✎ | Prostatype Genomics AB Stockholm | Option exercise via Liljeblad & Co Aktiebolag | 1,437,500 | SEK 0.10 | SEK 143,750.00 | ↗ |
| 15.09.2026✎ | Prostatype Genomics AB Stockholm | Option exercise via Liljeblad & Co Aktiebolag | 1,437,500 | — | No cash value 1,437,500 units | ↗ |
| 31.08.2026 | Prostatype Genomics AB Stockholm | Other / unclassified via Liljeblad & Co Aktiebolag | 2,875,000 | — | No cash value 2,875,000 units | ↗ |
| 31.08.2026 | Prostatype Genomics AB Stockholm | Other / unclassified via Liljeblad & Co Aktiebolag | 1,437,500 | — | No cash value 1,437,500 units | ↗ |
| 31.08.2026 | Prostatype Genomics AB Stockholm | Bought — open marketAcquisition via Liljeblad & Co Aktiebolag | 5,750,000 | SEK 0.10 | SEK 575,000.00 | ↗ |